Literature DB >> 16809039

Safe and efficacious probiotics: what are they?

Gregor Reid1.   

Abstract

Each year, >20 billion doses of probiotics are used by healthy people and by those diagnosed with a range of medical conditions. Compared to many pharmaceutical agents, probiotics are well tolerated and extremely safe, and serious adverse effects rarely occur. Nevertheless, as many new researchers enter the field and companies launch "probiotic" products, it is essential that standards are set for naming a product "probiotic" to show that it meets an acceptable level of safety and efficacy, and to understand the strengths and limitations of its activity. In this Opinion article, recommendations are made based upon the current understanding of scientific, clinical and regulatory issues, with a special focus on safety.

Entities:  

Mesh:

Year:  2006        PMID: 16809039     DOI: 10.1016/j.tim.2006.06.006

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  5 in total

1.  Probiotics and prebiotics: why are they "bugging" us in the pharmacy?

Authors:  Timothy Ulbrich; Steve Plogsted; Maureen E Geraghty; Kristina M Reber; Christina J Valentine
Journal:  J Pediatr Pharmacol Ther       Date:  2009-01

Review 2.  Probiotic products in Canada with clinical evidence: what can gastroenterologists recommend?

Authors:  G Reid; K Anukam; T Koyama
Journal:  Can J Gastroenterol       Date:  2008-02       Impact factor: 3.522

3.  Prospects for the development of probiotics and prebiotics for oral applications.

Authors:  Deirdre A Devine; Philip D Marsh
Journal:  J Oral Microbiol       Date:  2009-05-01       Impact factor: 5.474

4.  Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta-analysis of randomized controlled trials.

Authors:  Yong Jiang; Zhi-Guang Zhang; Feng-Xiang Qi; Ying Zhang; Tao Han
Journal:  Chronic Dis Transl Med       Date:  2016-08-09

5.  Effect of Simulated Gastrointestinal Tract Conditions on Survivability of Probiotic Bacteria Present in Commercial Preparations.

Authors:  Lidia Stasiak-Różańska; Anna Berthold-Pluta; Antoni Stanisław Pluta; Krzysztof Dasiewicz; Monika Garbowska
Journal:  Int J Environ Res Public Health       Date:  2021-01-27       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.